These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 29194971

  • 1. The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion.
    Nankivell BJ, Shingde M, Keung KL, Fung CL, Borrows RJ, O'Connell PJ, Chapman JR.
    Am J Transplant; 2018 Feb; 18(2):364-376. PubMed ID: 29194971
    [Abstract] [Full Text] [Related]

  • 2. T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.
    Lefaucheur C, Gosset C, Rabant M, Viglietti D, Verine J, Aubert O, Louis K, Glotz D, Legendre C, Duong Van Huyen JP, Loupy A.
    Am J Transplant; 2018 Feb; 18(2):377-390. PubMed ID: 29086461
    [Abstract] [Full Text] [Related]

  • 3. Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection?
    Nankivell BJ, P'Ng CH, Chapman JR.
    Am J Transplant; 2019 Jan; 19(1):132-144. PubMed ID: 29687946
    [Abstract] [Full Text] [Related]

  • 4. The clinical and pathological significance of borderline T cell-mediated rejection.
    Nankivell BJ, Agrawal N, Sharma A, Taverniti A, P'Ng CH, Shingde M, Wong G, Chapman JR.
    Am J Transplant; 2019 May; 19(5):1452-1463. PubMed ID: 30501008
    [Abstract] [Full Text] [Related]

  • 5. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
    Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, Duong van Huyen JP, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.
    Am J Transplant; 2018 Feb; 18(2):293-307. PubMed ID: 29243394
    [Abstract] [Full Text] [Related]

  • 6. Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.
    Modena BD, Kurian SM, Gaber LW, Waalen J, Su AI, Gelbart T, Mondala TS, Head SR, Papp S, Heilman R, Friedewald JJ, Flechner SM, Marsh CL, Sung RS, Shidban H, Chan L, Abecassis MM, Salomon DR.
    Am J Transplant; 2016 Jul; 16(7):1982-98. PubMed ID: 26990570
    [Abstract] [Full Text] [Related]

  • 7. Inflammation in areas of fibrosis: The DeKAF prospective cohort.
    Matas AJ, Helgeson ES, Gaston R, Cosio F, Mannon R, Kasiske BL, Hunsicker L, Gourishankar S, Rush D, Michael Cecka J, Connett J, Grande JP.
    Am J Transplant; 2020 Sep; 20(9):2509-2521. PubMed ID: 32185865
    [Abstract] [Full Text] [Related]

  • 8. i-IFTA and chronic active T cell-mediated rejection: A tale of 2 (DeKAF) cohorts.
    Helgeson ES, Mannon R, Grande J, Gaston RS, Cecka MJ, Kasiske BL, Rush D, Gourishankar S, Cosio F, Hunsicker L, Connett J, Matas AJ.
    Am J Transplant; 2021 May; 21(5):1866-1877. PubMed ID: 33052625
    [Abstract] [Full Text] [Related]

  • 9. Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas.
    Halloran PF, Matas A, Kasiske BL, Madill-Thomsen KS, Mackova M, Famulski KS.
    Am J Transplant; 2019 May; 19(5):1356-1370. PubMed ID: 30417539
    [Abstract] [Full Text] [Related]

  • 10. Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.
    Modena BD, Milam R, Harrison F, Cheeseman JA, Abecassis MM, Friedewald JJ, Kirk AD, Salomon DR.
    Am J Transplant; 2017 Mar; 17(3):712-723. PubMed ID: 27597148
    [Abstract] [Full Text] [Related]

  • 11. Challenges Posed by the Banff Classification: Diagnosis and Treatment of Chronic Active T-Cell-Mediated Rejection.
    Yamamoto I, Kawabe M, Hayashi A, Kobayashi A, Yamamoto H, Yokoo T.
    Nephron; 2023 Mar; 147 Suppl 1():74-79. PubMed ID: 36928337
    [Abstract] [Full Text] [Related]

  • 12. Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury.
    Stegall MD, Cornell LD, Park WD, Smith BH, Cosio FG.
    Am J Transplant; 2018 Jan; 18(1):180-188. PubMed ID: 28710896
    [Abstract] [Full Text] [Related]

  • 13. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
    García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV.
    Transplantation; 2017 Jun; 101(6):1410-1415. PubMed ID: 27163535
    [Abstract] [Full Text] [Related]

  • 14. Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.
    Bouatou Y, Viglietti D, Pievani D, Louis K, Duong Van Huyen JP, Rabant M, Aubert O, Taupin JL, Glotz D, Legendre C, Loupy A, Lefaucheur C.
    Am J Transplant; 2019 Jul; 19(7):1972-1988. PubMed ID: 30748089
    [Abstract] [Full Text] [Related]

  • 15. Cell mediated rejection revisited: Past, current, and future directions.
    Hara S.
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():45-51. PubMed ID: 29968416
    [Abstract] [Full Text] [Related]

  • 16. BK Virus Nephropathy: Histological Evolution by Sequential Pathology.
    Nankivell BJ, Renthawa J, Sharma RN, Kable K, O'Connell PJ, Chapman JR.
    Am J Transplant; 2017 Aug; 17(8):2065-2077. PubMed ID: 28371308
    [Abstract] [Full Text] [Related]

  • 17. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation.
    Fu Q, Liao M, Feng C, Tang J, Liao R, Wei L, Yang H, Markmann JF, Chen K, Deng S.
    Aging (Albany NY); 2019 Jul 25; 11(14):5215-5231. PubMed ID: 31343413
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.
    Matz M, Heinrich F, Lorkowski C, Wu K, Klotsche J, Zhang Q, Lachmann N, Durek P, Budde K, Mashreghi MF.
    PLoS One; 2018 Jul 25; 13(8):e0201925. PubMed ID: 30102719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.